Vendor review
WllyBIO reviews
WllyBIO reviews from 45 independent lab tests (Retatrutide, Tirzepatide and GHK-Cu): grade A, purity and fill accuracy. Is WllyBIO legit? See what its vials showed.
What the lab tests show
45 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Sep 30, 2026 | Retatrutide | 99.9 % | 19.99 mg of 20 mg (0 %) | Pass | View |
| Sep 5, 2026 | Tirzepatide | 99.9 % | 35.3 mg of 30 mg (18 %) | Pass | View |
| Aug 25, 2026 | Retatrutide | 99.8 % | 20.1 mg of 20 mg (1 %) | Pass | View |
| Aug 5, 2026 | GHK-Cu | 99.9 % | 49.2 mg of 50 mg (-2 %) | Pass | View |
| Aug 5, 2026 | Retatrutide | 15 mg | Fail | View | |
| Aug 4, 2026 | Tesamorelin | 5 mg | Fail | View | |
| Jun 15, 2026 | Retatrutide | 99.9 % | 9.44 mg of 10 mg (-6 %) | Pass | View |
| Jun 6, 2026 | Retatrutide | 99.8 % | 17.3 mg of 20 mg (-14 %) | Pass | View |
| Jun 6, 2026 | Retatrutide | 99.7 % | 20.2 mg of 20 mg (1 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.9 % | 27.3 mg of 30 mg (-9 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.9 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.9 % | 20.1 mg of 20 mg (1 %) | Pass | View |
| Dec 29, 2025 | Retatrutide | 99.9 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Dec 29, 2025 | GHK-Cu | 99.95 % | 44.8 mg of 50 mg (-10 %) | Pass | View |
| Dec 29, 2025 | Tirzepatide | 99.95 % | 9.71 mg of 10 mg (-3 %) | Pass | View |
| Nov 25, 2025 | Tesamorelin | 47.79 % | 5.35 mg of 10 mg (-47 %) | Pass | View |
| Nov 17, 2025 | Tirzepatide | 99.69 % | 23.3 mg of 20 mg (17 %) | Pass | View |
| Nov 17, 2025 | Tirzepatide | 99.95 % | 30.2 mg of 30 mg (1 %) | Pass | View |
| Nov 4, 2025 | Retatrutide | 99.7 % | 16.1 mg of 15 mg (7 %) | Pass | View |
| Oct 30, 2025 | Retatrutide | 99.6 % | 22.5 mg of 20 mg (13 %) | Pass | View |
| Oct 29, 2025 | Tirzepatide | 98.88 % | 4.16 mg of 5 mg (-17 %) | Pass | View |
| Oct 29, 2025 | BPC-157 | 99.5 % | 5.18 mg of 5 mg (4 %) | Pass | View |
| Oct 17, 2025 | Retatrutide | 99.77 % | 17.2 mg of 20 mg (-14 %) | Pass | View |
| Oct 17, 2025 | Retatrutide | 99.95 % | 61.7 mg of 50 mg (23 %) | Pass | View |
| Sep 30, 2025 | Retatrutide | 99.85 % | 4.73 mg of 5 mg (-5 %) | Pass | View |
| Sep 18, 2025 | Retatrutide | 99.89 % | 9.63 mg of 10 mg (-4 %) | Pass | View |
| Sep 18, 2025 | GHK-Cu | 99.72 % | 99.4 mg of 100 mg (-1 %) | Pass | View |
| Sep 10, 2025 | BPC-157 | 99.42 % | 4.95 mg of 5 mg (-1 %) | Pass | View |
| Sep 9, 2025 | Ipamorelin | 99.882 % | 4.21 mg of 5 mg (-16 %) | Pass | View |
| Aug 31, 2025 | Retatrutide | 99.9 % | 9.66 mg of 10 mg (-3 %) | Pass | View |
| Aug 31, 2025 | GHK-Cu | 99.95 % | 56.5 mg of 50 mg (13 %) | Pass | View |
| Aug 31, 2025 | GHK-Cu | 99.74 % | 47.1 mg of 50 mg (-6 %) | Pass | View |
| Aug 31, 2025 | Tirzepatide | 5 mg | Fail | View | |
| Aug 31, 2025 | Tirzepatide | 98.93 % | 9.9 mg of 10 mg (-1 %) | Pass | View |
| Aug 31, 2025 | Tirzepatide | 99.7 % | 15.3 mg of 15 mg (2 %) | Pass | View |
| Aug 31, 2025 | Tirzepatide | 99.8 % | 4.86 mg of 5 mg (-3 %) | Pass | View |
| Aug 31, 2025 | BPC-157 | 99.16 % | 9.89 mg of 10 mg (-1 %) | Pass | View |
| Aug 31, 2025 | BPC-157 | 96.76 % | 5.67 mg of 5 mg (13 %) | Pass | View |
| Aug 31, 2025 | Ipamorelin | 99.57 % | 4.43 mg of 5 mg (-11 %) | Pass | View |
| Aug 21, 2025 | Retatrutide | 99.94 % | 10.5 mg of 10 mg (5 %) | Pass | View |
| Jul 16, 2025 | GHK-Cu | 99.92 % | 88.45 mg of 100 mg (-12 %) | Pass | View |
| Jul 10, 2025 | Tesamorelin | 99.073 % | 3.38 mg of 5 mg (-32 %) | Pass | View |
| Jul 10, 2025 | Ipamorelin | 98.817 % | 4.22 mg of 5 mg (-16 %) | Pass | View |
| Jul 3, 2025 | Retatrutide | 99.31 % | 3.96 mg of 5 mg (-21 %) | Pass | View |
| Jul 3, 2025 | BPC-157 | 99.46 % | 7.18 mg of 10 mg (-28 %) | Pass | View |
What WllyBIO sells
No current listings on record.
About WllyBIO
Finnrick has tested 45 samples from WllyBIO across 6 products.